Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc. on December 20, 2023. The transaction is subject to certain regulatory approvals and closing conditions and is expected to be completed in the first quarter of 2024. TriMed founders David Medoff, Chief Commercial Officer, and Robert Medoff, MD, Medical Advisor, will continue to be a part of the management team of TriMed and bring to Henry Schein.

TriMed had 2022 net sales of approximately $48 million.